Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2025-03-27 Capital/Financing Update
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is a press release from CARMAT dated March 27, 2025, announcing the establishment of a flexible equity financing line with IRIS Capital Investment. The core subject is securing capital through the issuance of warrants (BSA - Bons de Souscription d'Actions) over a 24-month period. This directly relates to the company's fundraising and capital structure activities. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA), but the substance of the announcement itself concerns financing.
2025-03-27 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a formal declaration dated March 6, 2025, titled "Information relative au nombre total de droits de vote et d'actions composant le capital social" (Information relating to the total number of voting rights and shares comprising the share capital). It explicitly references Article 223-16 of the General Regulation of the Autorité des marchés financiers (AMF), which mandates the disclosure of the total number of shares and voting rights, typically on the 15th of the month or the last trading day of the preceding month. This content directly relates to the company's capital structure and share count disclosure, which falls under Share Issue/Capital Change (SHA) or potentially a general regulatory filing (RNS). Given the specific nature of reporting the total number of shares and voting rights, SHA is the most precise fit, as it deals with the composition of the capital.
2025-03-06 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release issued by CARMAT regarding the publication of a clinical study in 'The Journal of Heart and Lung Transplantation' concerning their Aeson® artificial heart. It does not constitute a financial report, an earnings release, or a regulatory filing of a specific financial nature. It is a general corporate announcement regarding research and development progress, which falls under the 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement.
2025-02-17 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT announcing the publication of a scientific study in 'The Journal of Heart and Lung Transplantation' regarding the performance of their Aeson artificial heart. It does not contain quarterly financial results, board changes, or regulatory filings, but rather serves as a general corporate announcement regarding clinical progress and research. As it does not fit into specific categories like 10-K, ER, or IR, it falls under the general regulatory/corporate announcement category.
2025-02-17 French
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is a press release issued by CARMAT announcing a corporate milestone (the 100th implant of their Aeson artificial heart). It does not constitute a formal financial report (10-K, IR), a transcript (CT), or a specific regulatory filing like a proxy or dividend notice. As it is a general corporate announcement regarding operational progress and business updates that does not fit into the more specific categories, it is classified as a Regulatory Filing (RNS).
2025-02-10 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release from CARMAT announcing a corporate milestone: reaching 100 implantations of their Aeson artificial heart. It provides operational updates, clinical progress, and management commentary. It does not constitute a formal financial report (10-K/IR), a regulatory filing, or a specific shareholder notice. As it is a general corporate announcement regarding company activities and operational progress, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-02-10 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.